Meridian Bioscience to Participate in Canaccord Genuity Virtual MedTech & Diagnostics Forum
November 16, 2020 12:00 ET
|
Meridian Bioscience Inc.
CINCINNATI, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) announced today that Jack Kenny, Chief Executive Officer, and Bryan Baldasare, Executive Vice President and...
Meridian Bioscience Reports Strong Fourth Quarter and Record Full-Year Fiscal 2020 Operating Results and Provides Fiscal 2021 Guidance
November 13, 2020 07:30 ET
|
Meridian Bioscience Inc.
CINCINNATI, Nov. 13, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the fourth quarter and fiscal year ended September 30, 2020. ...
Meridian Bioscience to Hold Fourth Quarter and Full Year 2020 Financial Results Conference Call on November 13, 2020
October 20, 2020 11:00 ET
|
Meridian Bioscience Inc.
CINCINNATI, Oct. 20, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, will report fourth quarter and full...
Meridian Bioscience Launches a Complete Solution to Support Liquid Biopsy Cancer Diagnostics
October 07, 2020 09:00 ET
|
Meridian Bioscience Inc.
CINCINNATI, Oct. 07, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading provider of diagnostic testing solutions and life science raw materials, announced today that it has...
Meridian launches a novel SARS-CoV-2 antibody pair designed for developing highly sensitive rapid antigen tests from saliva samples
September 14, 2020 10:00 ET
|
Meridian Bioscience Inc.
CINCINNATI, Sept. 14, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading provider of diagnostic testing solutions and life science critical raw materials, is pleased to...
Meridian Bioscience to Present at the H. C. Wainright 22nd Annual Global Investment Conference
August 31, 2020 08:00 ET
|
Meridian Bioscience Inc.
CINCINNATI, Aug. 31, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) announced today that Jack Kenny, Chief Executive Officer, and Bryan Baldasare, Executive Vice President and...
Meridian Bioscience Reports Fiscal Third Quarter 2020 Operating Results – Best Quarter in Company History – Raises Full Year Guidance
August 07, 2020 07:30 ET
|
Meridian Bioscience Inc.
CINCINNATI, Aug. 07, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the fiscal third quarter ended June 30, 2020. Third Quarter Fiscal...
Meridian Bioscience Announces New Board Member - Anthony Bihl
July 28, 2020 09:00 ET
|
Meridian Bioscience Inc.
CINCINNATI, July 28, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) announces the appointment of Anthony Bihl III to its Board of Directors, effective immediately. “We welcome...
Meridian Bioscience to Hold Third Quarter 2020 Financial Results Conference Call on August 7, 2020
July 16, 2020 09:00 ET
|
Meridian Bioscience Inc.
CINCINNATI, July 16, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, will report third quarter 2020...
Meridian Bioscience Announces the Launch of a High-Sensitivity SARS-CoV-2 Nucleocapsid Antibody Pair for the Development of Rapid COVID-19 Antigen Assays
July 13, 2020 13:00 ET
|
Meridian Bioscience Inc.
CINCINNATI, July 13, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading provider of diagnostic testing solutions and life science raw materials, announced today that it has...